US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Silo Pharma, Inc. - Common Stock
(NQ:
SILO
)
1.458
-0.042 (-2.80%)
Delayed Quote
Updated: 3:59 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silo Pharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 30, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
September 29, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
These stocks are gapping in today's session
↗
September 23, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
September 23, 2025
Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy
From
Silo Pharma, Inc.
Via
GlobeNewswire
EXCLUSIVE: Silo Pharma Partners With Fireblocks To Advance Crypto Treasury Strategy Acquisition And Security
↗
September 23, 2025
Silo Pharma partners with Fireblocks to secure its crypto treasury platform using multi-layer enterprise security and governance standards.
Via
Benzinga
These stocks are moving in today's pre-market session
↗
September 16, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
September 16, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
↗
September 09, 2025
3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.
Via
MarketBeat
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
September 09, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
September 03, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers
↗
September 02, 2025
Hoth Therapeutics reported strong preclinical efficacy and safety data for HT-KIT, a precision antisense therapy targeting KIT-driven cancers.
Via
Benzinga
Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
August 21, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 19, 2025
Via
Benzinga
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
August 19, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
August 05, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
July 16, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expects SPC-15 PTSD Study Results Within 90 Days
July 07, 2025
Via
Investor Brand Network
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
July 07, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via
Get News
Topics
Intellectual Property
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via
Press Release Distribution Service
Topics
Intellectual Property
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
June 11, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
June 11, 2025
From
Silo Pharma, Inc.
Via
GlobeNewswire
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
June 09, 2025
Via
Benzinga
Get insights into the top gainers and losers of Monday's pre-market session.
↗
June 09, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 09, 2025
Via
Benzinga
US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market'
↗
June 09, 2025
U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.
Via
Benzinga
Topics
Stocks
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
June 05, 2025
Strategic decision positions Company to diversify treasury holdings with a long-term digital store of value
From
Silo Pharma, Inc.
Via
GlobeNewswire
These stocks are moving in today's pre-market session
↗
June 05, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 05, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
